SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 9311596)

Published in Int J Cancer on September 04, 1997

Authors

J A Lednicky1, A R Stewart, J J Jenkins, M J Finegold, J S Butel

Author Affiliations

1: Division of Molecular Virology, Baylor College of Medicine, Houston, TX 77030-3498, USA.

Articles citing this

Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res (2008) 2.18

Simian virus 40 infection of humans. J Virol (2003) 1.71

Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30

Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis (2005) 1.25

Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev (2004) 1.10

Simian virus 40 in humans. Infect Agent Cancer (2007) 1.09

High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br J Cancer (2000) 0.98

Phylogenetic analysis of polyomavirus simian virus 40 from monkeys and humans reveals genetic variation. J Virol (2004) 0.97

PCR detection and DNA sequence analysis of the regulatory region of lymphotropic papovavirus in peripheral blood mononuclear cells of an immunocompromised rhesus macaque. J Clin Microbiol (2002) 0.93

Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. PLoS One (2013) 0.89

SV40 lymphomagenesis in Syrian golden hamsters. Virology (2008) 0.88

The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: there is no serological evidence of cross-reactivity with the simian polyoma virus SV40. Proc Natl Acad Sci U S A (1998) 0.85

Osteocytes serve as a progenitor cell of osteosarcoma. J Cell Biochem (2014) 0.83

Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters. J Virol (2007) 0.80

Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy. PLoS One (2014) 0.78

SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival. J Clin Pathol (2003) 0.77

Articles by these authors

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54

Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16

Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science (2001) 7.17

Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63

Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81

Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68

The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis (1985) 4.08

Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85

Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (1992) 3.54

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29

The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98

CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol (1997) 2.44

Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44

DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28

SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27

Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res (1997) 2.16

Subcellular Localization of simian virus 40 large tumor antigen. J Virol (1979) 2.03

A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03

Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochim Biophys Acta (1975) 1.95

Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95

Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94

Müllerian-inhibiting substance function during mammalian sexual development. Cell (1994) 1.85

Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol (1990) 1.80

Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79

Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol (1989) 1.76

Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev (1996) 1.75

Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73

Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest (1989) 1.72

Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.70

Dynamic specification of coarticulated vowels. J Acoust Soc Am (1983) 1.69

Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62

Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61

Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A (1994) 1.60

Pneumonic plague in monkeys. An electron microscopic study. Am J Pathol (1969) 1.60

Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. J Clin Oncol (1995) 1.58

Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice. Cell Growth Differ (1997) 1.57

Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56

Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr (1992) 1.56

Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther (1994) 1.50

Primary hepatic tumors of childhood. Hum Pathol (1983) 1.48

Identification of vowels in "vowelless" syllables. Percept Psychophys (1983) 1.45

Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43

Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol (2001) 1.42

Wilms' tumor: reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. Int J Radiat Oncol Biol Phys (1990) 1.38

A young woman with lymphoma and endocarditis. Lancet (1995) 1.38

Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology (1995) 1.37

Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience. Cancer (2000) 1.37

Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology (1993) 1.36

Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest (1988) 1.34

Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med (1985) 1.32

Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30

Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30

Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis. Am J Pathol (1968) 1.29

Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7. J Virol (1969) 1.28

The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol (1994) 1.27

Papovaviridae. Intervirology (1974) 1.26

Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26

The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J Virol (1991) 1.26

Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol (1997) 1.24

p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res (1992) 1.23

Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res (1991) 1.22

Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population. J Bacteriol (1966) 1.21

The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. Biochim Biophys Acta (1986) 1.21

Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res (1989) 1.21

Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21

Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen. J Virol (1969) 1.21

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol (1993) 1.19

Phenotypic consequences of lung-specific inducible expression of FGF-3. Proc Natl Acad Sci U S A (2001) 1.19

Demonstration of infectious deoxyribonucleic acid in transformed cells. I. Recovery of simian virus 40 from yielder and nonyielder transformed cells. J Virol (1972) 1.18

Modification of simian virus 40 large tumor antigen by glycosylation. Virology (1985) 1.18

Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. Virology (1982) 1.17

Interstitial pulmonary edema. An electron microscopic study of the pathology of staphylococcal enterotoxemia in Rhesus monkeys. Lab Invest (1967) 1.17

Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol (1998) 1.17

Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts. Mol Cell Biol (1986) 1.17

Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. J Pediatr (2007) 1.17

Studies with human papilloma virus modeled after known papovavirus systems. J Natl Cancer Inst (1972) 1.17

Pathogenesis of plague. A review of plague deaths in the United States during the last decade. Am J Med (1968) 1.16

Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv Cancer Res (1995) 1.16

Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A (1995) 1.15

Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res (2000) 1.15

Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol (2001) 1.15

Complementation between a defective monkey cell-adapting component and human adenoviruses in simian cells. Virology (1967) 1.14

Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice. Cancer Res (1980) 1.14

Biochemical characterization of nuclear and cytoplasmic forms of SV40 tumor antigens encoded by parental and transport-detective mutant SV40-adenovirus 7 hybrid viruses. Virology (1980) 1.12

Regenerating livers of old rats contain high levels of C/EBPalpha that correlate with altered expression of cell cycle associated proteins. Nucleic Acids Res (1998) 1.12

Familial congenital amputations. J Pediatr (1982) 1.12

Association of SV40 large tumor antigen and cellular proteins on the surface of SV40-transformed mouse cells. Virology (1982) 1.11

Cutaneous and subcutaneous Ewing's sarcoma: an indolent disease. Int J Radiat Oncol Biol Phys (2000) 1.11

Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J Clin Immunol (1995) 1.10

Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases. Med Pediatr Oncol (1995) 1.09

Lung structure in thoracic dystrophy. Am J Dis Child (1971) 1.09

Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg (1995) 1.09

Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther (1997) 1.08

Laryngeal papilloma: etiologic and therapeutic considerations. Ann Otol Rhinol Laryngol (1973) 1.08